Dreamer. Interested in science, science and society and methods of doing science and innovation. Tweeting here in personal capacity.
West Lafayette, IN
Joined May 2009
- Tweets2.1K
- Following693
- Followers1.6K
- Likes1.2K
doi.org/10.7554/eLife.98158 @eLife The elevator that transports what the operator sends. How to transport stolen human sugars into bacterial cells to enable recognition by immune system. @PurdueBiolSci @DBT_inStem @NCBS_Bangalore
Ramaswamy S retweeted
As the year draws to a close we are grateful to our all our investigators, donors and well wishers.
We wish you a Happy New Year 2025.
linkedin.com/feed/update/urn…
The binding architecture of a $2B drug - camlipixant to P2X3, described. See the paper by Thach, Vijayan and others.
jbc.org/article/S0021-9258(2…
@PurdueBiolSci @PurdueBME
fiercebiotech.com/biotech/af…
Ramaswamy S retweeted
Meet Shravanti Rampalli
This month's 'Meet the IgniteLSF Team' introduces @shravrampalli Rampalli, CEO.
@swami2m Subramaniam continues to be with us at Ignite in his new role of Member of the Scientific Advisory Board.”
linkedin.com/feed/update/urn…
Ramaswamy S retweeted
THE EKALAVYA-IGNITE TRAVEL GRANT APPLICATION IS OPEN for JAN TO MARCH 2024.
@SIMATS_Univ @SastraUniv @snbkol @unescorcb @RRI_Bangalore @RGCB_Trivandrum @rmrims
linkedin.com/feed/update/urn…
Ramaswamy S retweeted
THE EKALAVYA-IGNITE TRAVEL GRANT APPLICATION IS NOW OPEN
The application window for funding for travel to international meetings in JAN TO MARCH 2024 is now OPEN. Check our our LinkedIn Page
@IcmrNari @NABI_India @MAHE_Manipal @Themsubaroda @lcchennai @lvprasadeye
Ramaswamy S retweeted
BIO-PHARMA: In a groundbreaking development for #ophthalmology research, @EyestemResearch has completed the first set of three patient injections for its RPE suspension therapy for Dry age-related macular degeneration.
Click to read: biovoicenews.com/eyestem-com… via #BiovoiceNews
Have not posted in a long time. But, just came back from the Ignite annual meet with faith in Indian Philanthropy and Indian Science. @ignitelsf @gansbags
If you are in India, scan me and lets make science a movement.
Ramaswamy S retweeted
One step closer to market!
As part of its ongoing clinical trials, @EyestemResearch, a CCAMP supported & incubated startup has completed the first round of patient injections for treatment of dry age-related macular degeneration (AMD)!
🔗modernretina.com/view/eyeste……
AMD is a leading cause of blindness in individuals more than 60 years of age that impacts an estimated 196 million people globally
Eyestem's Eyecyte-RPE is an affordable stem cell based therapy aimed at combating geographic atrophy arising from dry AMD
9 patients with very low vision will be treated in the 1st phase of the trial while the second phase will treat 27 patients with intermediate vision loss in order to determine efficacy
@CCAMP_India @jogin_desai @DBTIndia @BIRAC_2012 @AIMtoInnovate @ITBTGoK @NITIAayog
Ramaswamy S retweeted
So far so good, next cohort looks closer! Exciting times! modernretina.com/view/eyeste…
@jogin_desai @BattuRajani @CCAMP_India @Taslimarif @BIRAC_2012
Ramaswamy S retweeted
Happy to be at the round table. Very important inititiative of US government and the Indian Government. @able_indiabio @BIRAC_2012 @theNASEM
Ramaswamy S retweeted
Our recently concluded Annual Meet had a tremendous response from doyens of industry, academicians, media and our grantees.
@RamonaParsani
linkedin.com/posts/ignite-li…
Ramaswamy S retweeted
We welcome OUR MOST RECENT AWARDEES in AgriScience
Eswar Ramireddy of @IiserTirupati
AND
Sanjana Reddy of ICAR - Indian Institute of Millets Research
linkedin.com/posts/ignite-li…
I was there and saw it. In 2003 I got stuck and had to stay overnight in TIFR. It is beautiful to watch. Bonus the company for the evening was also great @TIFRScience
Ramaswamy S retweeted
THE EKALAVYA-IGNITE TRAVEL GRANT APPLICATION IS NOW OPEN
@CUSBofficial @CUAP03940319 @CauImphal @CIAB_India @DBT_CDFD @bose_institute @BNHSIndia @BSIP_official @bmhrcbhopal @bhupro
linkedin.com/feed/update/urn…
Ramaswamy S retweeted
KanagaVijayan Dhanabalan et al.: Many locks to one key: N-acetylneuraminic acid binding to proteins #SialicAcid #Neu5Ac #GramNegativeBacteria @lifeatpurdue... #IUCr journals.iucr.org/paper?S205…
We feel safe that our lock can be opened with only one key. Drug discovery (Even though we know of side effects)assumes a lock and key mechanism. Nature is smart and has designed a key that binds to many locks. journals.iucr.org/m/issues/2… @PurdueBME @PurdueBiolSci
It is not often that we go back and read the PhD thesis of graduate students with whom you worked or collaborated. I had to do it when asked to write a Methods in enzymology article. Took me down memory lane. authors.elsevier.com/a/1jKlz… @PurdueBME @PurdueBiolSci